These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24363995)

  • 1. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
    Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
    Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
    Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
    Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
    Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+.
    Weitzel DH; Tovmasyan A; Ashcraft KA; Rajic Z; Weitner T; Liu C; Li W; Buckley AF; Prasad MR; Young KH; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Herndon JE; Batinic-Haberle I; Dewhirst MW
    Mol Cancer Ther; 2015 Jan; 14(1):70-9. PubMed ID: 25319393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
    Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
    Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection.
    Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Free Radic Biol Med; 2008 Mar; 44(6):982-9. PubMed ID: 18082148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
    Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
    Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.
    Celic T; Španjol J; Bobinac M; Tovmasyan A; Vukelic I; Reboucas JS; Batinic-Haberle I; Bobinac D
    Free Radic Res; 2014 Dec; 48(12):1426-42. PubMed ID: 25185063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
    Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
    Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
    Rebouças JS; Spasojević I; Batinić-Haberle I
    J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
    Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
    Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioprotective effect of a metalloporphyrin compound in rat eye model.
    Mao XW; Crapo JD; Mekonnen T; Lindsey N; Martinez P; Gridley DS; Slater JM
    Curr Eye Res; 2009 Jan; 34(1):62-72. PubMed ID: 19172472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.
    Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE
    Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
    Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
    Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.
    Mehrotra S; Pecaut MJ; Freeman TL; Crapo JD; Rizvi A; Luo-Owen X; Slater JM; Gridley DS
    Technol Cancer Res Treat; 2012 Oct; 11(5):447-57. PubMed ID: 22475066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.
    Sheng H; Spasojevic I; Tse HM; Jung JY; Hong J; Zhang Z; Piganelli JD; Batinic-Haberle I; Warner DS
    J Pharmacol Exp Ther; 2011 Sep; 338(3):906-16. PubMed ID: 21652782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).
    Pinto VH; Carvalhoda-Silva D; Santos JL; Weitner T; Fonseca MG; Yoshida MI; Idemori YM; Batinić-Haberle I; Rebouças JS
    J Pharm Biomed Anal; 2013 Jan; 73():29-34. PubMed ID: 22503130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2012 Nov; 26(11):1420-4. PubMed ID: 22783812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.